###### Strengths and limitations of this study

-   This is a multicentre, retrospective data analysis of complete atrioventricular block over a 15-year period.

-   This study included relatively small-sized patients in three referral centres in South Korea and may limit the generalisation of the results.

Introduction {#s1}
============

Pacemakers have been a definite treatment tool for symptomatic bradyarrhythmia to reduce cardiac morbidity and mortality.[@R1] However, chronic right ventricular (RV) pacing has a potentially deleterious effect on left ventricular (LV) function.[@R1] This deleterious effect of chronic RV pacing on LV function is known as pacing-induced cardiomyopathy (PICM).[@R1] Several studies have demonstrated that pacing anatomical site, pacing burden and preimplant LV dysfunction affect the occurrence of PICM and its subsequent clinical outcomes.[@R1] In particular, recognition of predictors for the occurrence of PICM may lead to better identification of patients at high risk for complete atrioventricular block (CAVB) with pacing-dependent rhythm. However, because PICM does not occur in all patients with CAVB with chronic RV pacing, timely and proper evaluation should be considered for those who most likely develop PICM.[@R7] Therefore, we retrospectively analysed a large cohort to identify the major determinants of the occurrence of PICM in patients with CAVB with pacing-dependent rhythm over a long period of time.

Method {#s2}
======

Study population {#s2a}
----------------

Consecutive patients with an implanted pacemaker were retrospectively collected from three different tertiary referral centres---Eulji University Hospital, Chungnam National University and Catholic St Mary's Hospital, which are located in Daejeon, South Korea---from December 2001 to August 2015. Among a total of 900 patients with an implanted pacemaker, patients with sick sinus syndrome, paroxysmal and advanced atrioventricular (AV) block (n=482), persistent/permanent atrial fibrillation (AF) (n=140) and preimplant LV dysfunction (n=148) combined with ischaemic heart disease,[@R10] including acute coronary syndrome, other proven cardiomyopathy or severe valvular disease at the preimplant period, were excluded from the study. Our investigators excluded pre-existing persistent/permanent AF which are considered risk factors for the occurrence of heart failure and could influence the relationship between CAVB and PICM. Thus, patients with CAVB (n=130) with documented preimplant and postimplant LV ejection fraction (LVEF) were analysed in this study (see online [supplementary figure 1](#SP5){ref-type="supplementary-material"}). All patients provided informed consent, and the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.
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LVEF was measured at Eulji University Hospital, Chungnam National University Hospital and St Mary's Hospital using standard echocardiographic techniques. Preimplant and postimplant (at least 1 day after the index implant) echocardiograms were performed and interpreted by two experienced cardiologists who were echocardiogram specialists (JY Chin at Eulji University Hospital and J-H Park at Chungnam National University Hospital). None of the patients developed myocardial infarction during the follow-up period, and the baseline clinical and demographic data, ECG and echocardiogram, and medication data were acquired from the electronic medical records.

ECG parameters, pacemaker data and definition of PICM {#s2b}
-----------------------------------------------------

Baseline ECG parameters were acquired from the ECG that was performed closest to the implant period using the standard criteria established by the American Heart Association and Heart Rhythm Society Expert Consensus.[@R11] RV pacing-leads sites were reviewed using the standard X-ray (see online [supplementary figure 2](#SP6){ref-type="supplementary-material"}). Pacemaker data were also acquired at regular intervals (at least 6 months), and the pacing burden (atrial and ventricular pacing %) was recorded at the time of follow-up and PICM diagnosis. Native QRS duration (nQRSd) was measured within 7 days at preimplant state, and paced QRS duration (pQRSd) was measured also within 7 days at the postimplant state from the surface 12-lead ECG.
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PICM was defined as greater than a 10% decrease in LVEF, with a resultant LVEF less than 50%, as previously reported,[@R7] regardless of heart failure symptoms[@R4] (see online [supplementary videos 1 and 2](#SP1 SP2){ref-type="supplementary-material"}). The time of PICM occurrence was considered the date of the first decrease in LVEF determined by echocardiogram with documented ECG at the time during the follow-up period.

Statistical analysis {#s2c}
--------------------

Baseline clinical, ECG, echocardiogram and pacemaker interrogation data of the enrolled patients were compared between those without PICM and with PICM using independent t-test and Χ^2^ test. To determine the independent predictors of PICM occurrence, the multivariate Cox regression hazard model was used for PICM. A receiver operating characteristic (ROC) curve was plotted to identify the cut-off value with the best sensitivity and specificity for the occurrence of PICM, and a Kaplan-Meier curve was plotted for free-from-PICM survival. Analyses were performed with the MedCalc software (V.17.0, Ostend, Belgium). P values \<0.05 were considered statistically significant.

Results {#s3}
=======

Comparison of baseline characteristics between patients with and without PICM {#s3a}
-----------------------------------------------------------------------------

Among all patients, 130 patients with CAVB with implanted pacemakers (dual-chamber: 84.6%) were suitable for the analysis of PICM in this study. The average age (64±11 years vs 62±11 years), the proportion of male (36.7% vs 33.3%) and the occurrence of AF (14.6% vs 14.2%) were detected among patients without PICM and with PICM during the follow-up period, and the mean duration of follow-up (4.8±3.5 years vs 4.2±3.5 years) was similar between patients without PICM and with PICM. Other baseline clinical characteristics, except for diabetes and previous stroke, were also similar between patients without PICM and with PICM. Among the laboratory data, haemoglobin and total bilirubin levels, which are associated with heart failure, were similar between patients without PICM and with PICM at preimplant and postimplant stages ([table 1](#T1){ref-type="table"}).

###### 

Baseline characteristics between patients with and without pacing-induced cardiomyopathy (PICM)

                                                All patients   Without PICM   With PICM   P value
  --------------------------------------------- -------------- -------------- ----------- ---------
  Age, years                                    64±11          64±11          62±11       0.472
  Male, n (%)                                   47 (36.2)      40 (36.7)      7 (33.3)    0.768
  Hypertension, n (%)                           75 (57.7)      58 (53.2)      16 (76.2)   0.146
  Diabetes, n (%)                               31 (24.0)      30 (27.5)      1 (5.0)     0.030\*
  Ischaemic heart disease, n (%)                15 (11.5)      11 (10.1)      4 (19.0)    0.239
  Stroke or transient ischaemic attack, n (%)   9 (6.9)        5 (4.6)        4 (19.0)    0.017\*
  Alcohol, n (%)                                16 (12.3)      13 (11.9)      3 (13.3)    0.763
  Smoking, n (%)                                18 (13.8)      16 (14.7)      2 (9.5)     0.531
  Haemoglobin, g/L                              12.3±2.1       12.1±1.9       12.4±2.6    0.660
  Total bilirubin, mg/dL                        1.0±0.8        1.0±0.6        1.0±0.8     0.556

\*Statistically significant.

Comparison of ECG data between patients with and without PICM {#s3b}
-------------------------------------------------------------

Among the 130 patients, 109 maintained normal LV function until the end of follow-up. The remainder of patients with CAVB (n=21, 16.1%) were considered to have PICM, with a decrease in LVEF from 65%±10% at baseline to 37%±8%. The follow-up ventricular pacing burden was similar between patients without PICM and with PICM (85%±18% vs 85%±17%). Compared with the patients without PICM, the patients who developed PICM had a significantly wider nQRSd (124±34 ms vs 149±32 ms, P=0.004), QTc interval (466±54 ms vs 495±44 ms, P=0.035) and pQRSd (139±29 ms vs 167±28 ms, P\<0.001) ([table 2](#T2){ref-type="table"}).

###### 

Comparison of ECG parameters between patients with and without PICM

                                              All patients   Without PICM   With PICM   P value
  ------------------------------------------- -------------- -------------- ----------- -----------
  Preimplant                                                                            
   Ejection fraction, n (%)                   65±10          66±9           65±10       0.607
   Left atrial diameter, mm                   39±9           38±7           40±8        0.552
   Heart rate, bpm                            60±30          57±18          60±12       0.550
   PR interval, ms                            190±81         170±115        213±130     0.203
   QRS duration, ms                           136±26         124±34         149±32      0.004\*
   QTc interval, ms                           480±37         466±54         495±44      0.035\*
  Postimplant                                                                           
   Dual-chamber, n (%)                        110 (84.6)     90 (82.5)      20 (95.2)   0.142
   Ejection fraction, n (%)                   45±8           61±7           37±8        \<0.001\*
   Left atrial diameter, mm                   40±7           39±7           40±6        0.266
   Occurrence of atrial fibrillation, n (%)   19 (14.6)      16 (14.6)      3 (14.2)    0.962
   Heart rate, bpm                            68±30          69±14          67±9        0.616
   PR interval, ms                            178±81         168±80         187±62      0.337
   Paced QRS duration, ms                     149±26         139±29         167±28      \<0.001\*
   Paced QRS axis, degree                     2±78           2±78           1±91        0.971
   Paced QTc interval, ms                     490±37         484±46         496±36      0.254
   Non-apical pacing, %                       51 (39.1)      44 (40.4)      7 (33.3)    0.546
   Atrial pacing, %                           23±22          23±23          22±22       0.954
   Ventricular pacing, %                      85±17          85±18          85±17       0.860

\*Statistically significant.

bpm, beats per minute; PICM, pacing-induced cardiomyopathy.

Comparison of medications between patients with and without PICM {#s3c}
----------------------------------------------------------------

Unlike patients without PICM, patients with PICM more frequently took ACE inhibitor or angiotensin II receptor blocker medication before implantation, and beta-blockers and diuretics after implantation, as shown in [table 3](#T3){ref-type="table"}.

###### 

Comparison of medications between patients with and without PICM

                         All patients   Without PICM   With PICM   P value
  ---------------------- -------------- -------------- ----------- ---------
  Preimplant                                                       
   ACEI or ARB, n (%)    50 (38.5)      37 (33.9)      13 (61.9)   0.016\*
   Beta-blocker, n (%)   16 (12.3)      11 (10.1)      5 (23.8)    0.080
   CCB, n (%)            26 (20.0)      22 (20.2)      4 (19.0)    0.905
   Diuretics, n (%)      30 (23.1)      22 (20.2)      8 (38.1)    0.074
  Postimplant                                                      
   ACEI or ARB, n (%)    58 (44.6)      45 (41.3)      13 (61.9)   0.082
   Beta-blocker, n (%)   22 (16.9)      15 (13.8)      7 (33.8)    0.029\*
   CCB, n (%)            31 (23.8)      28 (25.7)      3 (14.3)    0.262
   Diuretics, n (%)      32 (24.6)      23 (21.1)      9 (42.9)    0.034\*

\*Statistically significant.

ACEI, ACE inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; PICM, pacing-induced cardiomyopathy.

Predictors of PICM occurrence {#s3d}
-----------------------------

Multivariate Cox regression analysis showed that nQRSd had an HR of 1.01 and a 95% CI of 1.00 to 1.03 with a P value of 0.051, and that pQRSd had an HR of 1.05 and a 95% CI of 1.02 to 1.09 with a P value of \<0.001 ([table 4](#T4){ref-type="table"}). ROC curve analysis showed that a pQRSd above 140 ms had the combined best sensitivity (95%) and specificity (36%) and pQRSd above 167 ms had the combined sensitivity (52%) and best specificity (90%) for predicting the occurrence of PICM, with statistical significance ([figure 1](#F1){ref-type="fig"}). In the Kaplan-Meier curve, both pQRSd of 140 ms and 167 ms were significantly associated with the occurrence of PICM (log-rank, P=0.03 vs P\<0.001; [figure 2](#F2){ref-type="fig"}).

![Receiver operating characteristic curve analysis showing the pQRSd had correlated with the occurrence of pacing-induced cardiomyopathy and two rectangular black marks showing the best sensitivity (pQRSd 140 ms) and specificity (pQRSd 167 ms) with statistical significance. pQRSd, paced QRS duration.](bmjopen-2017-019048f01){#F1}

![Kaplan-Meier curve analysis showing free-from-PICM survival with a pQRSd (cut-off value of 140 ms and 167 ms). PICM, pacing-induced cardiomyopathy; pQRSd, paced QRS duration.](bmjopen-2017-019048f02){#F2}

###### 

Cox regression analysis for the occurrence of pacing-induced cardiomyopathy

                          Univariate   Multivariate                                     
  ----------------------- ------------ -------------- ----------- ------ -------------- ---------
  Age, per year           1.01         0.97 to 1.06   0.371                             
  Gender, male            0.90         0.35 to 2.30   0.833                             
  Diabetes mellitus       0.29         0.03 to 2.26   0.297                             
  nQRSd, per ms           1.02         1.00 to 1.04   0.010\*     1.01   1.00 to 1.03   0.051
  nQTc interval, per ms   1.00         0.99 to 1.08   0.195                             
  pQRSd, per ms           1.05         1.03 to 1.08   \<0.001\*   1.05   1.02 to 1.09   0.001\*
  Non-apical pacing       0.35         0.11 to 1.10   0.074                             

\*Statistically significant.

nQRSd, native QRS duration; pQRSd, paced QRS duration.

Discussion {#s4}
==========

In our study, among patients with CAVB with normal LV function at the preimplant period, PICM occurred in 16.1% of patients with pacing-dependent rhythm over a mean follow-up duration of 4.7±3.5 years. A pQRSd was significantly associated with the occurrence of PICM. In particular, a pQRSd wider than 140 ms had a sensitivity of 95% and a pQRSd of 167 ms had a specificity of 90% for predicting the occurrence of PICM.

Our result on the incidence of PICM over a long-term follow-up period is comparable with that from previous reports, ranging from 9% to 26% depending on the population investigated and the length of follow-up.[@R4] We also defined PICM as greater than a 10% decrease in LVEF, with a resultant LVEF less than 50% after the index implant. The time to the diagnosis of PICM was defined as the period from the date of implantation to the date of the first documented decrease in LVEF.

PICM has been widely considered as the pacing-associated heart failure.[@R1] The significance of PICM has been established for an increased risk in AF, heart failure hospitalisation and cardiac mortality.[@R9] The pacing site, increased pacing burden, preimplant LV dysfunction and QRS duration have been considered the independent predictors of PICM.[@R1]

First, with regard to the pacing site, a recent meta-analysis has suggested that the LVEF is higher in patients with RV non-apical pacing than those with RV apical pacing. However, this conclusion is still debated due to conflicting results.[@R3] In the PROTECT-PACE study, among patients with a high-grade AV block and preserved LV function, RV non-apical pacing did not have a protective effect on LV function compared with RV apical pacing over a 2-year period.[@R8] In addition, Chan *et al*[@R16] have previously reported that LV volumes and systolic function after long-term RV pacing could be predicted by pQRSd, but not pacing site. Our multicentre study also showed no significant difference between RV apical and non-apical pacing in the occurrence of PICM (40.4% vs 33.3%, P=0.546) among patients with CAVB with pacing-dependent rhythm over a long-term follow-up period.

Second, pacing burden has been considered a better predictor for the occurrence of PICM, and previous studies have shown heterogeneous percentages of pacing burden.[@R2] In our study, in patients with CAVB who required a high burden of permanent pacing, the confounding factor was minimised using homogeneous percentages of RV pacing (85% vs 85%, P=0.860) when analysing the predictors of PICM.

Third, with regard to preimplant LV dysfunction, previous studies had baseline pre-existing heart failure associated with coronary artery disease and AF,[@R4] and in the PREDICT-HF trial pre-existing heart failure was highly associated with pQRSd. Other studies have also found pQRSd to be an important predictor of heart failure among patients with chronic RV pacing.[@R13] In our study, all patients with CAVB with pre-existing LV systolic dysfunction (with or without heart failure) were excluded, and our results were reliable enough to include the analysis of PICM compared with previous studies.

Fourth, pacing-induced electrical dyssynchrony developed mechanical dyssynchrony; thus, the pQRSd could be a strong and independent determinant of the occurrence of PICM.[@R6] Our data also show that the pQRSd related to LV mechanical dyssynchrony has been confirmed to be significantly associated with LV remodelling (representative of the dyssynchrony index with strain in the two-dimensional or three-dimensional parameters; online [supplementary videos 3 and 4](#SP3 SP4){ref-type="supplementary-material"}), resulting in the occurrence of PICM by echocardiogram.

Pap *et al*[@R19] reported that nQRSd could be positively correlated with pQRSd, although the nQRSd as escape rhythm is influenced by the level of antegrade block on the His-Purkinje system during AV block. In addition, an nQRSd above 115 ms was highly specific (90%) for the occurrence of PICM, as reported in a single-centre study.[@R20] A single-centre study by Khurshid *et al*[@R13] also suggested that the nQRSd (HR=1.03 per ms; P\<0.001) is an independent predictor of PICM occurrence. In comparison, our study demonstrated that the proportion of patients with an nQRSd above 115 ms is higher in patients with PICM than those without PICM (74% vs 55%). In particular, the nQRSd (HR=1.02; P=0.010) was slightly significant in our univariate analysis and exhibited a positive trend (HR=1.01; P=0.051) in the multivariate analysis of the occurrence of PICM ([table 4](#T4){ref-type="table"}). It is implicated that a wider nQRSd may be a predisposition to cardiomyopathy. In particular, among patients with CAVB with normal LV function before implant, wider nQRSd may reflect more pathological electrical His-Purkinje conduction.

Miyoshi *et al*[@R21] also proposed that a pQRSd wider than 190 ms suggested a higher rate of morbidity than a pQRSd below 190 ms. However, the enrolled patients had ischaemic heart failure, valvular heart disease and other causes of cardiomyopathy, whereas our study did not. Chen *et al*[@R17] prospectively showed in 194 patients with CAVB without heart failure over a 3-year follow-up that clinical heart failure events were higher and the LVEF was lower among patients with a wider pQRSd. In addition, a pQRSd of 165 ms had the best specificity (67%) for predicting heart failure, and a single-centre study by Khurshid *et al*[@R13] also proposed that a pQRSd of 150 ms was a sensitive marker for PICM; however, those enrolled patients also had pre-existing AF, coronary artery disease and unknown cardiomyopathies.

Taken together, a wider pQRSd could be a major determinant of the occurrence of PICM. We also found that delayed signs and symptoms of heart failure reduce the early detection of PICM in patients with pacing-dependent rhythm and that not all patients with PICM meet the clinical criteria for heart failure despite a significant reduction of LVEF. This is consistent with previous studies showing only low sensitivity for the diagnosis of heart failure with reduced LV function.[@R22] Therefore, a more sensitive and specific marker for PICM occurrence may be required for patients with pacing-dependent rhythm.

Our study analysed a contemporary cohort of patients with CAVB and provided a detailed characterisation of the clinical, electrocardiographic, laboratory and echocardiographic data at both preimplant and postimplant periods, as well as at the end of the follow-up. In particular, it could be noteworthy that a multicentre study with a longer follow-up duration distinguish it from previous studies, as well as complement the previous studies.[@R13]

Patients with PICM mostly showed a prolonged pQRSd \>140 ms while those without PICM rarely show a prolonged pQRSd \>167 ms. Therefore, even though pQRSd correlates with the occurrence of PICM, pQRSd \<140 ms could exclude the occurrence of PICM and pQRSd \>167 ms could not exclude non-PICM state for follow-up.

Our findings suggest that patients with a wider pQRSd are at higher risk for developing PICM, and therefore these patients may benefit from routine echocardiographic screening for PICM and possibly a lower threshold for early biventricular or His-bundle pacing.[@R23]

This study included relatively small number of patients in the three referral centres in South Korea and may limit the generalisation of the results due to several limitations. First, our study was a retrospective study with unmeasured selection bias, and patients without preimplant or postimplant echocardiogram were excluded for analysis. Our study suffers from a small number of patients with PICM due to low incidence of PICM and lack of associations may be raised due to power issues. Second, this was a multicentre study, and thus the influence of different physicians on clinical decision-making may also influence the clinical variables associated with heart failure. Third, the definition of PICM was defined only with LVEF based on anecdotal evidence from a previous study. An appropriate universal definition of PICM is needed.[@R25] Fourth, while we excluded all potential aetiologies of heart failure, it is speculated that a wider nQRSd is associated with the occurrence of PICM because it reflects cardiomyopathy with normal LV function at preimplant stage. Thus, more detailed studies on the relationship between the nQRSd and an electrical pathology or substrate in patients with CAVB with normal LV function are needed. Fifth, the ability to upgrade to biventricular pacing or Hi-bundle pacing for a pQRSd over 150 ms was limited in patients with PICM in our study because of the strict coverage of the national health insurance.

Early detection and preventive management of PICM are challenging in patients with pacing-dependent rhythm because there are few data to guide clinicians in identifying subclinical and clinical PICM in the subsequent months to years after pacemaker implantation.

Conclusion {#s5}
==========

The occurrence of PICM in patients with pacing-dependent rhythm seems to be common but cannot be reliably diagnosed based on the conventional heart failure criteria. The pQRSd, which was more significant than the nQRSd, is associated with the occurrence of PICM. In particular, a patient with a pQRSd above 140 ms had the best sensitivity and a pQRSd above 167 ms had the best specificity of occurrence for PICM. Regardless of the pacing site, the pQRSd should be monitored for the timely evaluation and proper management of patients at high risk of PICM to reduce cardiac morbidity and mortality over a long follow-up period.
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